Modern Approaches to Localized Cancer of the Esophagus

Restricted access

The clinical spectrum of esophageal cancer has changed dramatically over the past couple of decades. Most notably, a profound rise in esophageal adenocarcinoma and decrease in the incidence of squamous carcinomas have occurred. An understanding of the factors that influence survival for patients with localized esophageal cancer has evolved concomitantly with these changes in epidemiology. Significant advancement in endoscopic and radiographic staging allows for more selective use of treatment modalities. The treatment of localized esophageal cancer mandates a multidisciplinary approach, with treatment tailored to disease extent, location, histology, and an accurate assessment of pretreatment staging. Despite these improvements in the staging and use of multimodality therapy, only modest improvements in patient survival have been observed. This article summarizes these modern approaches to localized cancer of the esophagus.

Correspondence: Robert E. Glasgow, MD, Department of Surgery, University of Utah, 30 North 1900 East, Salt Lake City, UT 84132. E-mail: robert.glasgow@hsc.utah.edu
  • 1

    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277300. Erratum in CA Cancer J Clin 2011;61:133–134.

  • 2

    Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549555.

    • Search Google Scholar
    • Export Citation
  • 3

    Brown L, Dewesa S, Chow W. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;100:12231232.

    • Search Google Scholar
    • Export Citation
  • 4

    Edge SB, Byrd DR, Comptom CC., eds. AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer; 2010:103115.

  • 5

    Ajani JA, Barthel JS, Bekaii-Saab T. NCCN Clinical Practice Guidelines in Oncology for esophageal cancer. J Natl Compr Canc Netw 2008;6:818849.

    • Search Google Scholar
    • Export Citation
  • 6

    Wijnhoven BP, Tran KT, Esterman A. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007;245:717725.

    • Search Google Scholar
    • Export Citation
  • 7

    Lund O, Hasenkam JM, Aagaard MT, Kimose HH. Time-related changes in characteristics of prognostic significance in carcinomas of the oesophagus and cardia. Br J Surg 1989;76:13011307.

    • Search Google Scholar
    • Export Citation
  • 8

    SEER: Surveillance Epidemiology and End Results database. Bethesda, MD: National Cancer Institute; April 15, 2011. Available at http://www.seer.cancer.gov/statfacts/html/esoph.html. Accessed March 13, 2011.

    • Search Google Scholar
    • Export Citation
  • 9

    Cen P, Hofstetter WL, Correa AM. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 2008;112:10201027.

    • Search Google Scholar
    • Export Citation
  • 10

    Barbour AP, Rizk NP, Gonen M. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol 2007;14:306316.

    • Search Google Scholar
    • Export Citation
  • 11

    Sepesi B, Watson TJ, Zhou D. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg 2010;210:418427.

    • Search Google Scholar
    • Export Citation
  • 12

    O'Riordan JM, Rowley S, Murphy JO. Impact of solitary involved lymph node on outcome in localized cancer of the esophagus and esophagogastric junction. J Gastrointest Surg 2007;11:493499.

    • Search Google Scholar
    • Export Citation
  • 13

    Thompson SK, Ruszkiewicz AR, Jamieson GG. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol 2008;15:34473458.

    • Search Google Scholar
    • Export Citation
  • 14

    Schomas DA, Quevedo JF, Donahue JM. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic. Dis Esophagus 2010;23:232239.

    • Search Google Scholar
    • Export Citation
  • 15

    Rasanen JV, Sihvo EI, Knuuti MJ. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003;10:954960.

    • Search Google Scholar
    • Export Citation
  • 16

    Lowe VJ, Booya F, Fletcher JG. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 2005;7:422430.

    • Search Google Scholar
    • Export Citation
  • 17

    Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 2006;15:751764.

    • Search Google Scholar
    • Export Citation
  • 18

    Downey RJ, Akhurst T, Ilson D. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003;21:428432.

    • Search Google Scholar
    • Export Citation
  • 19

    Yuan S, Yu Y, Chao KS. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med 2006;47:12551259.

    • Search Google Scholar
    • Export Citation
  • 20

    Shimpi RA, George J, Jowell P, Gress FG. Staging of esophageal cancer by EUS: staging accuracy revisited. Gastrointest Endosc 2007;66:475482.

  • 21

    Pech O, Gunter E, Dusemund F. Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer: results from a referral center for early esophageal cancer. Endoscopy 2010;42:456461.

    • Search Google Scholar
    • Export Citation
  • 22

    Smith BR, Chang KJ, Lee JG, Nguyen NT. Staging accuracy of endoscopic ultrasound based on pathologic analysis after minimally invasive esophagectomy. Am Surg 2010;76:12281231.

    • Search Google Scholar
    • Export Citation
  • 23

    Cen P, Hofstetter WL, Lee JH. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 2008;112:503510.

    • Search Google Scholar
    • Export Citation
  • 24

    Rampado S, Bocus P, Battaglia G. Endoscopic ultrasound: accuracy in staging superficial carcinomas of the esophagus. Ann Thorac Surg 2008;85:251256.

    • Search Google Scholar
    • Export Citation
  • 25

    Choi J, Kim SG, Kim JS. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc 2010;24:13801386.

    • Search Google Scholar
    • Export Citation
  • 26

    Walker AJ, Spier BJ, Perlman SB. Integrated PET/CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer. Mol Imaging Biol 2011;13:166171.

    • Search Google Scholar
    • Export Citation
  • 27

    Vazquez-Sequeiros E, Norton ID, Clain JE. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 2001;53:751757.

    • Search Google Scholar
    • Export Citation
  • 28

    Birkmeyer JD, Siewers AE, Finlayson EV. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:11281137.

  • 29

    Birkmeyer NJ, Goodney PP, Stukel TA. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 2005;103:435441.

    • Search Google Scholar
    • Export Citation
  • 30

    Ancona E, Rampado S, Cassaro M. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008;15:32783288.

  • 31

    Ell C, May A, Pech O. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007;65:310.

    • Search Google Scholar
    • Export Citation
  • 32

    Pech O, May A, Gossner L. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 2007;39:3035.

    • Search Google Scholar
    • Export Citation
  • 33

    Peters FP, Kara MA, Rosmolen WD. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 2005;61:506514.

    • Search Google Scholar
    • Export Citation
  • 34

    Pouw RE, Peters FP, Sempoux C. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort. Endoscopy 2008;40:892898.

    • Search Google Scholar
    • Export Citation
  • 35

    Dimick JB, Wainess RM, Upchurch GR Jr. National trends in outcomes for esophageal resection. Ann Thorac Surg 2005;79:212216; discussion 217–218.

    • Search Google Scholar
    • Export Citation
  • 36

    Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:22412252.

  • 37

    Wright CD, Kucharczuk JC, O'Brien SM. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. J Thorac Cardiovasc Surg 2009;137:587595; discussion 596.

    • Search Google Scholar
    • Export Citation
  • 38

    Wong J. Esophageal resection for cancer: the rationale of current practice. Am J Surg 1987;153:1824.

  • 39

    Barbour AP, Rizk NP, Gonen M. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007;246:18.

    • Search Google Scholar
    • Export Citation
  • 40

    Groth SS, Virnig BA, Whitson BA. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. J Thorac Cardiovasc Surg 2010;139:612620.

    • Search Google Scholar
    • Export Citation
  • 41

    Rizk NP, Ishwaran H, Rice TW. Optimum lymphadenectomy for esophageal cancer. Ann Surg 2010;251:4650.

  • 42

    Fiorica F, Di Bona D, Schepis F. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004;53:925930.

    • Search Google Scholar
    • Export Citation
  • 43

    Gebski V, Burmeister B, Smithers BM. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8:226234.

    • Search Google Scholar
    • Export Citation
  • 44

    Jin HL, Zhu H, Ling TS. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol 2009;15:59835991.

    • Search Google Scholar
    • Export Citation
  • 45

    Gaast AV, van Hagen P, Hulshof M. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study. J Clin Oncol 2010;28:15s.

    • Search Google Scholar
    • Export Citation
  • 46

    Stahl M, Stuschke M, Lehmann N. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005;23:23102317.

    • Search Google Scholar
    • Export Citation
  • 47

    Bedenne L, Michel P, Bouche O. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007;25:11601168.

    • Search Google Scholar
    • Export Citation
  • 48

    Minsky BD, Pajak TF, Ginsberg RJ. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:11671174.

    • Search Google Scholar
    • Export Citation
  • 49

    Cunningham D, Allum WH, Stenning SP. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:1120.

    • Search Google Scholar
    • Export Citation
  • 50

    Okines AF, Norman AR, McCloud P. Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Ann Oncol 2009;20:15291534.

    • Search Google Scholar
    • Export Citation
  • 51

    Allum WH, Stenning SP, Bancewicz J. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009;27:50625067.

    • Search Google Scholar
    • Export Citation
  • 52

    Kelsen DP, Winter KA, Gunderson LL. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 2007;25:37193725.

    • Search Google Scholar
    • Export Citation
  • 53

    Rice TW, Adelstein DJ, Chidel MA. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 2003;126:15901596.

    • Search Google Scholar
    • Export Citation
  • 54

    Kleinberg L, Powell ME, Forastiere AA. Survival outcome of E1201: an Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/radiotherapy (RT) or irinotecan/cisplatin/RT in endoscopy with ultrasound (EUS) staged esophageal adenocarcinoma [abstract]. J Clin Oncol 2008;26:Abstract 4532.

    • Search Google Scholar
    • Export Citation
  • 55

    Urba SG, Orringer MB, Ianettonni M. Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma. Cancer 2003;98:21772183.

    • Search Google Scholar
    • Export Citation
  • 56

    van Meerten E, Muller K, Tilanus HW. Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Br J Cancer 2006;94:13891394.

    • Search Google Scholar
    • Export Citation
  • 57

    Kleinberg L, Knisely JP, Heitmiller R. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2003;56:328334.

    • Search Google Scholar
    • Export Citation
  • 58

    Khushalani NI, Leichman CG, Proulx G. Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. J Clin Oncol 2002;20:28442850.

    • Search Google Scholar
    • Export Citation
  • 59

    Sharma R, Yang GY, Nava HR. A single institution experience with neoadjuvant chemoradiation (CRT) with irinotecan (I) and cisplatin (C) in locally advanced esophageal carcinoma (LAEC) [abstract]. J Clin Oncol 2009;27(Suppl 1):Abstract e15619.

    • Search Google Scholar
    • Export Citation
  • 60

    Schnirer II, Komaki R, Yao JC. Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction. Am J Clin Oncol 2001;24:9195.

    • Search Google Scholar
    • Export Citation
  • 61

    Cooper JS, Guo MD, Herskovic A. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:16231627.

    • Search Google Scholar
    • Export Citation
  • 62

    Conroy T, Yataghene Y, Etienne PL. Definitive chemoradiotherapy (CRT) with folfox 4 or 5FU-cisplatin as first line treatment for patients (pts) with inoperable esophageal cancer (IEC): final results of a randomized phase II study [abstract]. J Clin Oncol 2007;25(Suppl 1):Abstract 4532.

    • Search Google Scholar
    • Export Citation
  • 63

    Macdonald JS, Smalley SR, Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725730.

    • Search Google Scholar
    • Export Citation
  • 64

    Ajani JA, Winter K, Okawara GS. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol 2006;24:39533958.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 1 0 0
Full Text Views 128 109 2
PDF Downloads 36 33 0
EPUB Downloads 0 0 0